Our work is guided by our commitment to bring new innovations to patients and AAA is dedicated to developing treatments for several leading types of cancer through the application of precision, targeted radioligand therapy. Our ambition is to leverage industry leading pipeline to unlock the benefit of radioligand therapy across different tumor types. Our goal is to reimagine nuclear medicine.